HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy.

Inclusion body myopathy multisystem proteinopathy muscle proteomics neuromyopathy proteogenomics vacuolar myopathy

Journal

Journal of neuromuscular diseases
ISSN: 2214-3602
Titre abrégé: J Neuromuscul Dis
Pays: Netherlands
ID NLM: 101649948

Informations de publication

Date de publication:
07 Aug 2024
Historique:
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 9 8 2024
Statut: aheadofprint

Résumé

HNRNPA1 variants are known to cause degenerative motoneuron and muscle diseases which manifests in middle age or later. We report on a girl with early childhood onset, rapidly progressive generalized myopathy including ultrastructural findings in line with a proteinopathy. Proteomics of patient-derived muscle and combined screening of genomic data for copy number variations identified a HNRNPA1 de novo intragenic deletion as causative for the phenotype. Our report expands the spectrum of HNRNPA1-related diseases towards early-childhood onset and adds HNRNPA1 to the growing list of ALS and myopathy genes for which certain mutations may cause severe pediatric phenotypes.

Identifiants

pubmed: 39121134
pii: JND240050
doi: 10.3233/JND-240050
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Andreas Roos (A)

Department of Neuropediatrics and Neuromuscular Centre for Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, Essen, Germany.
Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Division of Neurology, Department of Medicine, Children' s Hospital of Eastern Ontario Research Institute, The Ottawa Hospital, and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.

Martin Häusler (M)

Division of Neuropediatrics and Social Pediatrics, Department of Paediatrics, RWTH Aachen University Hospital, Aachen, Germany.

Laxmikanth Kollipara (L)

Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V. Dortmund, Germany.

Ana Topf (A)

John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.

Corinna Preusse (C)

Department of Neuropathology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Rolf Stucka (R)

Department of Neurology, Friedrich-Baur Institute, Ludwig-Maximilians University Munich, Munich, Germany.

Kay Nolte (K)

Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.

Tim Strom (T)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Riccardo Berutti (R)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Institute of Neurogenomics, Computational Health Centre, Helmholtz Zentrum München, Neuherberg, Germany.

Xuehui Jiang (X)

Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Canada.

Randi Koll (R)

Department of Neuropathology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Hanns Lochmüller (H)

Division of Neurology, Department of Medicine, Children' s Hospital of Eastern Ontario Research Institute, The Ottawa Hospital, and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.
Centro Nacional de Análisis Genómico (CNAG), Barcelona, Catalonia, Spain.
Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Sabine Maria Schacht (SM)

Department of Diagnostic and Interventional Radiology, University Hospital RWTH 52074 Aachen, Germany.

René P Zahedi (RP)

Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V. Dortmund, Germany.
Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Canada.
Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada.
Cancer Care Manitoba Research Institute, Winnipeg, Canada.

Joachim Weis (J)

Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.

Jan Senderek (J)

Department of Neurology, Friedrich-Baur Institute, Ludwig-Maximilians University Munich, Munich, Germany.

Classifications MeSH